Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 19, 2023
DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates
Sascha A L Mueller, Jonathan A Oler, Patrick H Roseboom, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 19, 2015
Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons
Daniel J Urban, Hu Zhu, Catherine A Marcinkiewcz, et al.
Research Square
|
March 30, 2023
Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone
Michael Michaelides, Marjorie Levinstein, Paulo De Oliveira, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
<i>In vivo</i> photopharmacology with light-activated opioid drugs
Shannan P McClain, Xiang Ma, Desiree A Johnson, et al.
Journal of Medicinal Chemistry
|
January 19, 2026
Discovery of Fluorinated Ultrapotent Chemogenetic Ligands for PET Imaging and Neural Modulation in Nonhuman Primates
Sridhar Goud Nerella, Jeih-San Liow, Bing Li, et al.
Pharmacological Research
|
June 16, 2025
Locomotor activity depends on β-arrestin recruitment by the dopamine D<sub>1</sub> receptor in the striatal D<sub>1</sub>-D<sub>3</sub> receptor heteromer
Alexandra H Evans, Marc Ciruela-Jardí, William Rea, et al.
Translational Psychiatry
|
November 9, 2021
Synaptic Zn<sup>2+</sup> potentiates the effects of cocaine on striatal dopamine neurotransmission and behavior
Juan L Gomez, Jordi Bonaventura, Jacqueline Keighron, et al.
Nature Communications
|
October 22, 2024
Preexisting risk-avoidance and enhanced alcohol relief are driven by imbalance of the striatal dopamine receptors in mice
Miriam E Bocarsly, Marlisa J Shaw, Emilya Ventriglia, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects
Ryan P Cantwell Chater, Julian Peiser-Oliver, Tanmay K Pati, et al.
Nature Communications
|
February 16, 2026
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects
Ryan P Cantwell Chater, Julian Peiser-Oliver, Tanmay K Pati, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Biorxiv : the Preprint Server for Biology
|
June 19, 2023
DREADD-mediated amygdala activation is sufficient to induce anxiety-like responses in young nonhuman primates
Sascha A L Mueller, Jonathan A Oler, Patrick H Roseboom, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 19, 2015
Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons
Daniel J Urban, Hu Zhu, Catherine A Marcinkiewcz, et al.
Research Square
|
March 30, 2023
Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone
Michael Michaelides, Marjorie Levinstein, Paulo De Oliveira, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
<i>In vivo</i> photopharmacology with light-activated opioid drugs
Shannan P McClain, Xiang Ma, Desiree A Johnson, et al.
Journal of Medicinal Chemistry
|
January 19, 2026
Discovery of Fluorinated Ultrapotent Chemogenetic Ligands for PET Imaging and Neural Modulation in Nonhuman Primates
Sridhar Goud Nerella, Jeih-San Liow, Bing Li, et al.
Pharmacological Research
|
June 16, 2025
Locomotor activity depends on β-arrestin recruitment by the dopamine D<sub>1</sub> receptor in the striatal D<sub>1</sub>-D<sub>3</sub> receptor heteromer
Alexandra H Evans, Marc Ciruela-Jardí, William Rea, et al.
Translational Psychiatry
|
November 9, 2021
Synaptic Zn<sup>2+</sup> potentiates the effects of cocaine on striatal dopamine neurotransmission and behavior
Juan L Gomez, Jordi Bonaventura, Jacqueline Keighron, et al.
Nature Communications
|
October 22, 2024
Preexisting risk-avoidance and enhanced alcohol relief are driven by imbalance of the striatal dopamine receptors in mice
Miriam E Bocarsly, Marlisa J Shaw, Emilya Ventriglia, et al.
Biorxiv : the Preprint Server for Biology
|
December 3, 2025
A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects
Ryan P Cantwell Chater, Julian Peiser-Oliver, Tanmay K Pati, et al.
Nature Communications
|
February 16, 2026
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects
Ryan P Cantwell Chater, Julian Peiser-Oliver, Tanmay K Pati, et al.
Page
of 12